3 of the Best Consumer Staples Stocks in 2026

The article highlights Philip Morris, Coca-Cola, and Chewy as attractive consumer staples ideas, emphasizing Philip Morris’s 5%-7% organic revenue growth outlook, Coca-Cola’s 10% Q1 organic revenue growth, and Chewy’s 90 bps EBITDA margin expansion to 5.7%. Coca-Cola is benefiting from volume recovery, while Chewy is targeting another 100 bps of margin expansion this year and a 10% long-term EBITDA margin goal. Overall, it is bullish commentary on defensive consumer names rather than a company-specific catalyst.

Analysis

The common thread is not “defensive” per se; it is pricing power plus mix shift. PM’s smoke-free and KO’s concentrate economics both convert modest top-line growth into disproportionately strong earnings durability, while CHWY is the opposite lever: a structurally lower-margin business trying to re-rate through operating leverage. That means the market is paying for different qualities in each name — PM/KO for resilience and compounding, CHWY for a credible path to margin inflection — but the shared risk is that any slowdown in consumption would first show up in mix and promotional intensity before it hits reported revenue.

The second-order effect is that PM and KO can likely keep compounding even if unit growth stalls, but CHWY is more sensitive to fulfillment efficiency and ad monetization execution. For CHWY, the market is underwriting a multi-quarter margin expansion story; if logistics savings or private-label penetration slip by even 50-100 bps, the multiple can compress quickly because the valuation is still anchored to “future EBITDA,” not current cash flow. Conversely, if autoship retention remains stable while sponsored ads and pharmacy scale, the operating leverage could surprise to the upside within 2-3 quarters.

The consensus may be underestimating how much of PM’s upside is already in the smoke-free story and how much of KO’s near-term upside depends on volume staying positive rather than just pricing. PM looks less like a classic value setup and more like a quality-duration trade with regulatory event risk; KO looks like a low-volatility compounder where upside is incremental, not explosive. CHWY is the clearest catalyst-driven name, but it also has the widest dispersion: it can rerate materially if margins approach the low end of the long-term target sooner than expected, or derate hard if consumer trade-down pressures start showing up in basket mix.

Key Decisions for Investors

• Long KO on a 6-12 month horizon as a defensive compounding trade; reward is steady EPS progression with lower drawdown risk, but upside is capped unless volume acceleration persists.
• Long PM only on pullbacks or via staged entries over 1-2 months; treat it as a cash-flow durability trade, not a high-conviction multiple expansion idea, with regulatory/news risk as the main tail risk.
• Initiate a tactical long CHWY position for a 3-6 month catalyst window if you believe margin expansion will continue; use a smaller sizing than KO/PM because variance around execution is materially higher.
• Pair trade: long CHWY / short a broad consumer staples basket if you want to express operating leverage over defensiveness; the thesis works if margin gains outpace slower-growth staples over the next two quarters.
• Avoid chasing PM after strength; if the stock rerates on smoke-free optimism, consider trimming into strength because the market may already be discounting much of the medium-term growth path.